Endo, Inc.: Endo Announces Agreement for Paladin Pharma to Commercialize Wynzora Cream in Canada
Endo, Inc. (OTCQX: NDOI) announced today that it has entered into a definitive agreement with MC2 Therapeutics ("MC2") to commercialize Wynzora® Cream ...
Endo Announces Agreement for Paladin Pharma to Commercialize Wynzora® Cream in Canada
Endo, Inc. (OTCQX: NDOI) announced today that it has entered into a definitive agreement with MC2 Therapeutics ("MC2") to commercialize Wynzora® Cream (calcipotriene and betamethasone dipropionate) in ...
Chronic Lower Back Pain (CLBP) Market Size On Track To Surpass USD 5.52 Billion By 2032 At A 9.2% CAGR VMR
Chronic Lower Back Pain (CLBP) market Research Report Covers, Future Trends, Past, Present Data and Deep Analysis ...
PharmiWeb3d
MultiOmic Health announces discovery of novel endotypes and biomarkers for diabetic kidney disease
MultiOmic Health, a leading AI-enabled drug discovery company, announces the identification of novel patient endotypes and the development of proprietary biomarkers for stratifying diabetic kidney ...